A Study of Adalimumab on Inflammatory Mediators Following a Systemic Endotoxin Challenge
Condition(s):HealthyLast Updated:September 13, 2023Completed
Hide Studies Not Open or Pending
Condition(s):HealthyLast Updated:September 13, 2023Completed
Condition(s):Parkinson’s DiseaseLast Updated:November 13, 2014Completed
Condition(s):Lupus NephritisLast Updated:May 6, 2015Unknown status
Condition(s):DepressionLast Updated:November 5, 2021Withdrawn
Condition(s):LPS Challenge, NeutrophilsLast Updated:May 7, 2014Completed
Condition(s):Sickness BehaviorLast Updated:June 11, 2018Completed
Condition(s):Innate Immune ResponseLast Updated:June 7, 2011Completed
Condition(s):HealthyLast Updated:March 31, 2023Completed
Condition(s):Healthy VolunteersLast Updated:March 29, 2021Terminated
Condition(s):MelanomaLast Updated:August 12, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.